Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 11/2019

Inhalt (22 Artikel)

Original Article – Cancer Research

Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening

Jie Li, Huawei Xu, Lixing Zhang, Lele Song, Dan Feng, Xiaobo Peng, Meihong Wu, Yang Zou, Bin Wang, Lixing Zhan, Guoqiang Hua, Xianbao Zhan

Original Article – Cancer Research

CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach

Vivek Anand, Madhuram Khandelwal, Sandeep Appunni, Nidhi Gupta, Amlesh Seth, Prabhjot Singh, Sandeep Mathur, Alpana Sharma

Original Article – Cancer Research

Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer

Cuiling Zhou, Gang Che, Xiaobin Zheng, Junlan Qiu, Zhinan Xie, Yunyan Cong, Xiaofeng Pei, Hongyu Zhang, Huanhuan Sun, Haiqing Ma

Original Article – Cancer Research

Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells

Jelena Mihajlović, Laura A. M. Diehl, Andreas Hochhaus, Joachim H. Clement

Original Article – Cancer Research

Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases

Florian Bösch, Rumyana Todorova, Helena Link, C. Benedikt Westphalen, Stefan Boeck, Volker Heinemann, Jens Werner, Thomas Kirchner, Martin K. Angele, Jens Neumann

Open Access Original Article – Cancer Research

Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer

Nicole Golob-Schwarzl, Christina Wodlej, Florian Kleinegger, Margit Gogg-Kamerer, Anna Maria Birkl-Toeglhofer, Johannes Petzold, Ariane Aigelsreiter, Michael Thalhammer, Young Nyun Park, Johannes Haybaeck

Original Article – Cancer Research

A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer

Lele Liu, Xingguo Song, Xinyi Li, Linlin Xue, Shanshan Ding, Limin Niu, Li Xie, Xianrang Song

Original Article – Cancer Research

MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer

Sophie Baumgart, Pascal Meschkat, Philipp Edelmann, Joana Heinzelmann, Alexey Pryalukhin, Rainer Bohle, Julia Heinzelbecker, Michael Stöckle, Kerstin Junker

Open Access Original Article – Cancer Research

Outcome in serous ovarian cancer is not associated with LATS expression

Céline Montavon, Gregor R. Stricker, Andreas Schoetzau, Viola Heinzelmann-Schwarz, Francis Jacob, André Fedier

Review – Clinical Oncology

Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence

Yuyang Ze, Xiaowen Zhang, Fei Shao, Lin Zhu, Shanmei Shen, Dalong Zhu, Yan Bi

Original Article – Clinical Oncology

Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger

Original Article – Clinical Oncology

Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China

Bing Chen, Wenjie Xia, Zhongqiu Wang, Heng Zhao, Xiaofei Li, Lunxu Liu, Yang Liu, Jian Hu, Xiangning Fu, Yin Li, Yijun Xu, Deruo Liu, Haiying Yang, Lin Xu, Feng Jiang

Original Article – Clinical Oncology

Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients

Karin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, Judith Feucht, Patrick Schlegel, Markus Dobratz, Christian Seitz, Ingo Müller, Peter Lang, Rupert Handgretinger, Michaela Döring

Original Article – Clinical Oncology

Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series

Wanpeng Li, Hanyu Lu, Dehui Wang

Original Article – Clinical Oncology

Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype

Irina Demina, Elena Zerkalenkova, Olga Illarionova, Yulia Olshanskaya, Tatiana Verzhbitskaya, Alexandra Semchenkova, Grigory Tsaur, Ekaterina Rusanova, Margarita Belogurova, Ludmila Baidun, Svetlana Plyasunova, Tatiana Konyuhova, Anna Kazakova, Larisa Fechina, Galina Novichkova, Elena Samochatova, Natalia Myakova, Alexey Maschan, Alexander M. Popov

Original Article – Clinical Oncology

Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments

C. Ostheimer, C. Evers, F. Palm, R. Mikolajczyk, D. Vordermark, Daniel Medenwald

Original Article – Clinical Oncology

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

Niels Smedegaard Andersen, Martin Bornhäuser, Martin Gramatzki, Peter Dreger, Antonin Vitek, Michal Karas, Mauricette Michallet, Carol Moreno, Michel van Gelder, Anja Henseler, Liesbeth C. de Wreede, Stefan Schönland, Nicolaus Kröger, Johannes Schetelig

Original Article – Clinical Oncology

5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes

Anja L. Gawlitza, Johanna Speith, Jenny Rinke, Roman Sajzew, Elena K. Müller, Vivien Schäfer, Andreas Hochhaus, Thomas Ernst

Original Article – Clinical Oncology

Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial

Susanne Singer, Helge Danker, Jürgen Meixensberger, Susanne Briest, Andreas Dietz, Rolf-Dieter Kortmann, Jens-Uwe Stolzenburg, Anette Kersting, Julia Roick

Open Access Original Article – Clinical Oncology

Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients

Karl R. Aigner, Sabine Gailhofer, Emir Selak, Kornelia Aigner

Original Article – Clinical Oncology

Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy

Sang Hun Song, Chang Hee Ye, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Jong Jin Oh

Letter to the Editors

Impact of 9q deletions on the classification of patients with acute myeloid leukemia

Bettina Balk, Torsten Haferlach, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Anna Stengel

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.